Notice of Commission Determination Not To Review an Initial Determination Granting a Motion for Return of a Bond; Certain Microfluidic Systems and Components Thereof and Products Containing Same, 70527 [2021-26717]

Download as PDF Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Notices INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1100] Notice of Commission Determination Not To Review an Initial Determination Granting a Motion for Return of a Bond; Certain Microfluidic Systems and Components Thereof and Products Containing Same U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission (‘‘Commission’’) has determined not to review an initial determination (‘‘ID’’) (Order No. 46) of the presiding administrative law judge (‘‘ALJ’’), granting respondent Bio-Rad Laboratories, Inc.’s motion for return of the bond it posted during the period of Presidential Review. FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708–5453. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission instituted this investigation based on a complaint filed by 10X Genomics, Inc. of Pleasanton, CA (‘‘10X’’). 83 FR 7491 (Feb. 21, 2018). The complaint alleged violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain microfluidic systems and components thereof and products containing same by reason of infringement of one or more claims of U.S. Patent Nos. 9,644,204; 9,689,024; 9,695,468; and 9,856,530. Id. The Commission’s notice of investigation named as the sole respondent Bio-Rad Laboratories, Inc. of Hercules, CA (‘‘BioRad’’). Id. The Office of Unfair Import Investigations participated in this investigation. Id. jspears on DSK121TN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:03 Dec 09, 2021 Jkt 256001 On February 12, 2020, the Commission issued its opinion and final determination in this investigation, which found Bio-Rad in violation of section 337. The Commission also issued remedial orders on that date and set a bond of twenty-five percent (25%) of the entered value of the articles subject to the remedial orders during the period of Presidential review. Pursuant to that bond provision, Bio-Rad posted bond in the amount of $6,554.68. On July 26, 2021, Bio-Rad agreed to a settlement resolving the dispute in this investigation. Pursuant to a joint request by Bio-Rad and 10X, the Commission reviewed the settlement agreement and issued an order rescinding the remedial orders in this investigation on August 25, 2021. See 86 FR 48441–42 (Aug. 30, 2021). On July 28, 2021, shortly after entering the settlement agreement with 10X, Bio-Rad moved without opposition for the return of its bond. On October 21, 2021, the presiding ALJ issued the subject ID, which granted Bio-Rad’s motion. No petitions for review of that ID have been received. The Commission has determined not to review the subject ID. The bond at issue is ordered to be returned to BioRad. The Commission vote for this determination took place on December 6, 2021. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: December 6, 2021. Lisa Barton, Secretary to the Commission. [FR Doc. 2021–26717 Filed 12–9–21; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1209] Certain Movable Barrier Operator Systems and Components Thereof; Commission Decision To Review in Part a Final Initial Determination Finding a Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, the Public Interest, and Bonding; Target Date Extension U.S. International Trade Commission. AGENCY: PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 ACTION: 70527 Notice. Notice is hereby given that the U.S. International Trade Commission has determined to review in part a final initial determination (‘‘FID’’) of the presiding administrative law judge (‘‘ALJ’’) finding a violation of section 337 of the Tariff Act of 1930, as amended. The Commission requests briefing from the parties on certain issues under review, as set forth in this notice. The Commission also requests briefing from the parties, interested persons, and government agencies on the issues of remedy, the public interest, and bonding. The Commission has further determined to extend the target date until February 3, 2022. SUMMARY: FOR FURTHER INFORMATION CONTACT: Houda Morad, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708–4716. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. On August 10, 2020, the Commission instituted this investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (‘‘section 337’’), based on a complaint filed by Overhead Door Corporation of Lewisville, Texas and GMI Holdings Inc. of Mount Hope, Ohio (collectively, ‘‘Complainants’’). See 85 FR 48264–65 (Aug. 10, 2020). The complaint, as supplemented, alleges a violation of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain movable barrier operator systems and components thereof by reason of infringement of U.S. Patent Nos. 8,970,345 (‘‘the ’345 patent’’); 9,483,935 (‘‘the ’935 patent’’); 7,173,516 (‘‘the ’516 patent’’); 7,180,260 (‘‘the ’260 patent’’); 7,956,718 (‘‘the ’718 patent’’); and 8,410,895 (‘‘the ’895 patent’’). See id. The notice of investigation names The Chamberlain Group, Inc. of Oak Brook, Illinois (‘‘Respondent’’) as the respondent in this investigation. See id. The Office of Unfair Import SUPPLEMENTARY INFORMATION: E:\FR\FM\10DEN1.SGM 10DEN1

Agencies

[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
[Notices]
[Page 70527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26717]



[[Page 70527]]

=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1100]


Notice of Commission Determination Not To Review an Initial 
Determination Granting a Motion for Return of a Bond; Certain 
Microfluidic Systems and Components Thereof and Products Containing 
Same

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission (``Commission'') has determined not to review an initial 
determination (``ID'') (Order No. 46) of the presiding administrative 
law judge (``ALJ''), granting respondent Bio-Rad Laboratories, Inc.'s 
motion for return of the bond it posted during the period of 
Presidential Review.

FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of 
the General Counsel, U.S. International Trade Commission, 500 E Street 
SW, Washington, DC 20436, telephone (202) 708-5453. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. General information concerning the Commission may 
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on 
this matter can be obtained by contacting the Commission's TDD terminal 
on (202) 205-1810.

SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission 
instituted this investigation based on a complaint filed by 10X 
Genomics, Inc. of Pleasanton, CA (``10X''). 83 FR 7491 (Feb. 21, 2018). 
The complaint alleged violations of section 337 of the Tariff Act of 
1930, as amended, 19 U.S.C. 1337, in the importation into the United 
States, the sale for importation, or the sale within the United States 
after importation of certain microfluidic systems and components 
thereof and products containing same by reason of infringement of one 
or more claims of U.S. Patent Nos. 9,644,204; 9,689,024; 9,695,468; and 
9,856,530. Id. The Commission's notice of investigation named as the 
sole respondent Bio-Rad Laboratories, Inc. of Hercules, CA (``Bio-
Rad''). Id. The Office of Unfair Import Investigations participated in 
this investigation. Id.
    On February 12, 2020, the Commission issued its opinion and final 
determination in this investigation, which found Bio-Rad in violation 
of section 337. The Commission also issued remedial orders on that date 
and set a bond of twenty-five percent (25%) of the entered value of the 
articles subject to the remedial orders during the period of 
Presidential review. Pursuant to that bond provision, Bio-Rad posted 
bond in the amount of $6,554.68.
    On July 26, 2021, Bio-Rad agreed to a settlement resolving the 
dispute in this investigation. Pursuant to a joint request by Bio-Rad 
and 10X, the Commission reviewed the settlement agreement and issued an 
order rescinding the remedial orders in this investigation on August 
25, 2021. See 86 FR 48441-42 (Aug. 30, 2021).
    On July 28, 2021, shortly after entering the settlement agreement 
with 10X, Bio-Rad moved without opposition for the return of its bond. 
On October 21, 2021, the presiding ALJ issued the subject ID, which 
granted Bio-Rad's motion. No petitions for review of that ID have been 
received.
    The Commission has determined not to review the subject ID. The 
bond at issue is ordered to be returned to Bio-Rad.
    The Commission vote for this determination took place on December 
6, 2021.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: December 6, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021-26717 Filed 12-9-21; 8:45 am]
BILLING CODE 7020-02-P